These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6428755)

  • 1. Natural killer cell defects resulting from thermal injury.
    Stein MD; Gamble DN; Klimpel KD; Herndon DN; Klimpel GR
    Cell Immunol; 1984 Jul; 86(2):551-6. PubMed ID: 6428755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective NK cell activity following thermal injury.
    Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
    Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood lymphocytes from thermal injury patients are defective in their ability to generate lymphokine-activated killer (LAK) cell activity.
    Klimpel GR; Herndon DH; Stein MD
    J Clin Immunol; 1988 Jan; 8(1):14-22. PubMed ID: 2966807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay.
    Bradley TP; Bonavida B
    Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates.
    Nair MP; Schwartz SA; Menon M
    Cell Immunol; 1985 Aug; 94(1):159-71. PubMed ID: 3926326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells in the blood and bone marrow of the rhesus monkey.
    Gengozian N; Longley RE; Filler J; Good RA
    Cell Immunol; 1986 Aug; 101(1):24-38. PubMed ID: 3742605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell inhibition of young spherules and endospores of Coccidioides immitis.
    Petkus AF; Baum LL
    J Immunol; 1987 Nov; 139(9):3107-11. PubMed ID: 2444651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
    Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
    J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of natural killer-cell function in humans following thermal and traumatic injury.
    Blazar BA; Rodrick ML; O'Mahony JB; Wood JJ; Bessey PQ; Wilmore DW; Mannick JA
    J Clin Immunol; 1986 Jan; 6(1):26-36. PubMed ID: 3485653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.
    Ruco LP; Procopio A; Maccallini V; Calogero A; Uccini S; Annino L; Mandelli F; Baroni CD
    Blood; 1983 Jun; 61(6):1132-7. PubMed ID: 6220750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
    Degliantoni G; Murphy M; Kobayashi M; Francis MK; Perussia B; Trinchieri G
    J Exp Med; 1985 Nov; 162(5):1512-30. PubMed ID: 3932579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of interferon-alpha (MOR-22) on human NK cell activity].
    Yanagihara Y; Tochizawa S; Ishii K; Hirai Y
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):342-8. PubMed ID: 3947110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's syndrome.
    Nair MP; Schwartz SA
    Clin Immunol Immunopathol; 1984 Dec; 33(3):412-24. PubMed ID: 6209046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
    Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
    Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.